Search
for
Sort by
Research 391–420 of 1000+
- Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth
- 59 Scarring alopecia is driven by the collapse of EGFR-protected JAK-STAT1-sensitive stem cell immune privilege
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- Advances in the mechanism and new therapies of alopecia areata
- Effectiveness of Tofacitinib in Pre-adolescent Alopecia Areata: A Retrospective Case Series and Literature Review
- Real-Life Effectiveness and Tolerance of Baricitinib for the Treatment of Severe Alopecia Areata with 1-Year Follow-Up Data
- A superb way to split hairs
- 43647 Treatment of Refractory Folliculitis Decalvans with the Topical JAK Inhibitor Tofacitinib
- 43046 Outcomes of Down-Titration in Patients with Severe Scalp Alopecia Areata Treated with Baricitinib 4 Mg: Week 104 Data from BRAVE-AA2
- Topical metformin as a novel therapy for alopecia areata due to its immunologic effects
- Survey of pediatric dermatologist views on treatment for alopecia areata
- Treatment modalities for lymphocytic and neutrophilic scarring alopecia
- An Updated in the Management of Alopecia Areata
- Androgenetic alopecia: An update
- Markers of Venous Thromboembolism Risk in Patients with Alopecia Areata: Is There Anything to Worry about?
- An Overview about Alopecia Areata Etiopathogenesis, Diagnosis, and Management: Review Article
- Treatment Patterns and Unmet Needs in the Management of Alopecia Areata: Results of a Physician’s Survey in the Middle East
- P64 Efficacy of baricitinib in patients with different degrees of severe alopecia areata: 52-week results from BRAVE-AA1 and BRAVE-AA2
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Systemic immunotherapies
- ISID1108 - Comparison of ruxolitinib and a collagen-targeted PTH-based hair cycle stimulant on hair follicle counts and hair growth in the C3H/HeJ engrafted mouse model of alopecia areata.
- A Promising Efficacy of Tofacitinib in an Adult Patient with Alopecia Areata
- Tofacitinib: A Promising Treatment for Adolescent Alopecia Areata
- Review of efficacy of baricitinib in the treatment of alopecia areata
- 504 A single-center retrospective study evaluating the efficacy of intravenous methylprednisolone pulse therapy for 113 patients with alopecia areata
- Baricitinib for alopecia areata
- Pattern hair loss distribution: a novel presentation for alopecia areata
- Analyzing the role of tofacitinib in treatment of alopecia areata: A retrospective analysis from a tertiary care center of North India
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Alopecia areata in children: an overview of clinical features and recent treatment options